What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized?
Tattevin
Pierre
P
Camus
Christophe
C
D000081:Acetamides / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D005334:Fever; D006801:Humans; D000069349:Linezolid; D009503:Neutropenia / Q000188:drug therapy*; D023303:Oxazolidinones / Q000627:therapeutic use*; D014640:Vancomycin / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use*
D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D014640:Vancomycin; D000069349:Linezolid